Company Filing History:
2 out of 2,103 
1 out of 19 
1 out of 1 Years Active: 2019-2020
Title: Paul Nakamura: Innovator in Retinal Disease Treatment
Introduction
Paul Nakamura is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of retinal disease treatment. With a total of two patents to his name, Nakamura has focused on innovative methods that aim to improve the quality of life for individuals suffering from retinal conditions.
Latest Patents
Nakamura's latest patents include groundbreaking methods for the treatment of retinal disease through photoreceptor gene expression modulation. These patents detail methods for decreasing rod gene expression in the retina, as well as techniques for reducing the protein products expressed by rod genes. His work emphasizes the treatment of diseases or conditions that can be addressed by decreasing rod gene expression or their protein products in the retina. Additionally, he has developed methods specifically aimed at treating retinal diseases in subjects.
Career Highlights
Throughout his career, Paul Nakamura has worked with esteemed institutions such as the University of Washington and The J. David Gladstone Institutes, a testamentary trust established under the will of J. David Gladstone. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Nakamura has collaborated with notable colleagues, including Thomas A. Reh and Sheng Ding, further enhancing the impact of his research in the field of retinal disease treatment.
Conclusion
Paul Nakamura's innovative work in retinal disease treatment showcases his dedication to improving patient outcomes through scientific advancements. His patents reflect a commitment to addressing complex medical challenges, making him a significant figure in the realm of medical innovation.